USA Banner

Official US Government Icon

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure Site Icon

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

U.S. Department of Transportation U.S. Department of Transportation Icon United States Department of Transportation United States Department of Transportation

Interpretation Response #25-0063

Below is the interpretation response detail and a list of regulations sections applicable to this response.

Interpretation Response Details

Response Publish Date:

Company Name: Transportation Development Group LLC

Individual Name: Jim Powell

Location State: AZ Country: US

View the Interpretation Document

Response text:

August 7, 2025

Jim Powell
President
Transportation Development Group LLC
190 W. Continental Rd, Suite 216-401
Green Valley, AZ  85614

Reference No. 25-0063

Dear Mr. Powell:

This letter is in response to your April 21, 2025 email requesting clarification of the Hazardous Materials Regulations (HMR; 49 CFR Parts 171-180) applicable to the transportation of Division 6.2 (Infectious substance) materials. Specifically, you requested clarification on the transportation of HIV+ blood for the purposes of an autologous blood transfusion and whether it is subject to the requirements of the HMR.

Section 173.134(b) lists materials not subject to the HMR as Division 6.2 infectious substances. This includes, in accordance with § 173.134(b)(7), blood, regardless of whether it contains an infectious substance, collected for the purposes of a blood transfusion.

I hope this information is helpful. Please contact us if we can be of further assistance.

Sincerely,

Dirk DerKinderen
Chief, Standards and Development Branch
Standards and Rulemaking Division

§ 173.134(b)(7)

Regulation Sections